Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations

Clinical trial NCT05300048 · TERMINATED

Trial details

NCT number: NCT05300048
Sponsor: Faeth Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor PIK3CA Mutation PTEN Loss of Function Mutation

Start date: 2022-04-22
Primary completion: 2025-04-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.